DK1308159T3
(da)
*
|
1995-09-21 |
2005-02-14 |
Pharma Pass Ii Llc |
Farmaceutisk sammensætning indeholdende en syre-labil omeprazol og fremgangsmåde til fremstilling deraf
|
US6489346B1
(en)
|
1996-01-04 |
2002-12-03 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
US5840737A
(en)
|
1996-01-04 |
1998-11-24 |
The Curators Of The University Of Missouri |
Omeprazole solution and method for using same
|
US6645988B2
(en)
|
1996-01-04 |
2003-11-11 |
Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
US6699885B2
(en)
*
|
1996-01-04 |
2004-03-02 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and methods of using same
|
SE9602442D0
(sv)
*
|
1996-06-20 |
1996-06-20 |
Astra Ab |
Administration of pharmaceuticals
|
SE9700885D0
(sv)
*
|
1997-03-12 |
1997-03-12 |
Astra Ab |
New pharmaceutical formulation
|
US6197331B1
(en)
|
1997-07-24 |
2001-03-06 |
Perio Products Ltd. |
Pharmaceutical oral patch for controlled release of pharmaceutical agents in the oral cavity
|
WO1999004816A1
(en)
*
|
1997-07-25 |
1999-02-04 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Proton pump inhibitor in therapeutic combination with antibacterial substances
|
DE19732903A1
(de)
|
1997-07-30 |
1999-02-04 |
Falk Pharma Gmbh |
Pellet-Formulierung zur Behandlung des Intestinaltraktes
|
ES2137862B1
(es)
*
|
1997-07-31 |
2000-09-16 |
Intexim S A |
Preparacion farmaceutica oral que comprende un compuesto de actividad antiulcerosa y procedimiento para su obtencion.
|
WO1999018938A1
(en)
*
|
1997-10-09 |
1999-04-22 |
Perio Products Ltd. |
Delayed total release gastrointestinal drug delivery system
|
SE9704869D0
(sv)
*
|
1997-12-22 |
1997-12-22 |
Astra Ab |
New pharmaceutical formulaton II
|
SE9704870D0
(sv)
*
|
1997-12-22 |
1997-12-22 |
Astra Ab |
New pharmaceutical formulation I
|
WO1999043327A1
(fr)
*
|
1998-02-24 |
1999-09-02 |
Kaneka Corporation |
Compositions antimicrobiennes a effet synergique, medicaments et remedes pour maladies digestives contenant ces compositions, leur procede de production et preparations associees
|
EP1069911A1
(en)
*
|
1998-04-06 |
2001-01-24 |
Dalhousie University |
A novel nitroreductase and therapeutic uses therefor
|
DE19820801A1
(de)
*
|
1998-05-09 |
1999-11-25 |
Gruenenthal Gmbh |
Orale Arzneiformen mit reproduzierbarer Wirkstofffreisetzung von Gatifloxacin oder pharmazeutisch verwendbaren Salzen oder Hydraten
|
US7122207B2
(en)
|
1998-05-22 |
2006-10-17 |
Bristol-Myers Squibb Company |
High drug load acid labile pharmaceutical composition
|
PT1105105E
(pt)
*
|
1998-08-12 |
2006-07-31 |
Altana Pharma Ag |
Forma de administracao oral para piridin-2-ilmetilsulfinil-1h-benzimidazois
|
US6531152B1
(en)
|
1998-09-30 |
2003-03-11 |
Dexcel Pharma Technologies Ltd. |
Immediate release gastrointestinal drug delivery system
|
DE19850445A1
(de)
*
|
1998-11-02 |
2000-05-04 |
Falk Pharma Gmbh |
Arzneimittel zur topischen Behandlung entzündlicher Darmerkrankungen
|
JP4610086B2
(ja)
|
1998-11-18 |
2011-01-12 |
アストラゼネカ・アクチエボラーグ |
改善された化学的方法および医薬処方物
|
US6632451B2
(en)
|
1999-06-04 |
2003-10-14 |
Dexcel Pharma Technologies Ltd. |
Delayed total release two pulse gastrointestinal drug delivery system
|
ES2168043B1
(es)
*
|
1999-09-13 |
2003-04-01 |
Esteve Labor Dr |
Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido.
|
US10179130B2
(en)
|
1999-10-29 |
2019-01-15 |
Purdue Pharma L.P. |
Controlled release hydrocodone formulations
|
BRPI0015284B8
(pt)
|
1999-10-29 |
2021-05-25 |
Euro Celtique S/A |
formulações de hidrocodona de liberação controlada
|
US6544555B2
(en)
|
2000-02-24 |
2003-04-08 |
Advancis Pharmaceutical Corp. |
Antibiotic product, use and formulation thereof
|
DE10030318C1
(de)
*
|
2000-06-27 |
2002-02-28 |
Byk Gulden Lomberg Chem Fab |
Arzneimittelverpackung für die Eradikationstherapie
|
WO2002026210A2
(en)
*
|
2000-09-29 |
2002-04-04 |
Geneva Pharmaceuticals Inc. |
Proton pump inhibitor formulation
|
US20020068078A1
(en)
|
2000-10-13 |
2002-06-06 |
Rudnic Edward M. |
Antifungal product, use and formulation thereof
|
KR101045144B1
(ko)
|
2000-10-30 |
2011-06-30 |
유로-셀티크 소시에떼 아노뉨 |
서방성 하이드로코돈 제형
|
CA2359812C
(en)
*
|
2000-11-20 |
2004-02-10 |
The Procter & Gamble Company |
Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
|
US7988999B2
(en)
*
|
2000-12-07 |
2011-08-02 |
Nycomed Gmbh |
Pharmaceutical preparation in the form of a paste comprising an acid-labile active ingredient
|
JP2002234842A
(ja)
*
|
2001-02-09 |
2002-08-23 |
Kyowa Yakuhin Kogyo Kk |
内服腸溶性製剤
|
SE0101379D0
(sv)
*
|
2001-04-18 |
2001-04-18 |
Diabact Ab |
Komposition som hämmar utsöndring av magsyra
|
US20030070584A1
(en)
|
2001-05-15 |
2003-04-17 |
Cynthia Gulian |
Dip coating compositions containing cellulose ethers
|
AU4061702A
(en)
*
|
2001-05-15 |
2003-04-03 |
Mcneil-Ppc, Inc. |
Dip coating compositions containing starch or dextrin
|
EP1404300B1
(en)
|
2001-06-22 |
2009-09-30 |
Pfizer Products Inc. |
Pharmaceutical compositions of dispersions of drugs and neutral polymers
|
BR0210530A
(pt)
*
|
2001-06-22 |
2004-06-22 |
Pfizer Prod Inc |
Composições farmacêuticas de drogas e poìimeros acìdicos neutralizados
|
US8309118B2
(en)
|
2001-09-28 |
2012-11-13 |
Mcneil-Ppc, Inc. |
Film forming compositions containing sucralose
|
FR2830447B1
(fr)
*
|
2001-10-09 |
2004-04-16 |
Flamel Tech Sa |
Forme galenique orale microparticulaire pour la liberation retardee et controlee de principes actifs pharmaceutiques
|
US8101209B2
(en)
|
2001-10-09 |
2012-01-24 |
Flamel Technologies |
Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
|
US20040006111A1
(en)
*
|
2002-01-25 |
2004-01-08 |
Kenneth Widder |
Transmucosal delivery of proton pump inhibitors
|
DE10211289A1
(de)
|
2002-03-14 |
2003-09-25 |
Basf Ag |
Kombination von Polyvinylacetat von wasserunlöslichen, säureunlöslichen oder alkaliunlöslichen Polymeren zur Hestellung von Filmüberzügen mit sehr kontrollierter Freisetzung und hoher Stabilität
|
US20030175342A1
(en)
*
|
2002-03-14 |
2003-09-18 |
Karl Kolter |
Coated pharmaceutical single-unit delayed-release forms, based on polyvinyl acetate
|
CN100577164C
(zh)
*
|
2002-04-09 |
2010-01-06 |
弗拉梅技术公司 |
可改进释放阿莫西林的微囊含水混悬液形式的口服药物制剂
|
EP1492511B3
(fr)
|
2002-04-09 |
2012-05-02 |
Flamel Technologies |
Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiee de principe(s) actif(s)
|
US7125563B2
(en)
|
2002-04-12 |
2006-10-24 |
Dava Pharmaceuticals, Inc. |
Sustained release pharmaceutical preparations and methods for producing the same
|
US20030228363A1
(en)
*
|
2002-06-07 |
2003-12-11 |
Patel Mahendra R. |
Stabilized pharmaceutical compositons containing benzimidazole compounds
|
BR0312347A
(pt)
*
|
2002-07-05 |
2005-04-12 |
Temrel Inc |
Composição farmacêutica oral, usos da espessura de revestimento de um material de revestimento dependente do ph de dissolução, de um material de revestimento, e de um material de polimetacrilato
|
US20040013737A1
(en)
*
|
2002-07-19 |
2004-01-22 |
Philippe Becourt |
Taste masked oral composition of telithromycin
|
WO2004009059A1
(en)
*
|
2002-07-19 |
2004-01-29 |
Aventis Pharma S.A. |
Taste masked oral composition of telithromycin
|
CA2488860A1
(en)
*
|
2002-07-25 |
2004-02-05 |
Pharmacia Corporation |
Method of preparing solid dosage forms coated in two layers comprising a water-insoluble polymer and a water-soluble pore former
|
US7429619B2
(en)
*
|
2002-08-02 |
2008-09-30 |
Mcneil Consumer Healthcare |
Polyacrylic film forming compositions
|
US20040028737A1
(en)
*
|
2002-08-12 |
2004-02-12 |
Kopran Research Laboratories Limited |
Enteric coated stable oral pharmaceutical composition of acid unstable drug and process for preparing the same
|
EP1530460A2
(en)
*
|
2002-08-16 |
2005-05-18 |
Themis Laboratories Private Limited |
A process for manufacture of stable oral multiple units pharamceutical composition containing benzimidazoles
|
US20050191353A1
(en)
*
|
2002-08-16 |
2005-09-01 |
Amit Krishna Antarkar |
Process for manufacture of stable oral multiple unit pharmaceutical composition containing benzimidazoles
|
MY148805A
(en)
*
|
2002-10-16 |
2013-05-31 |
Takeda Pharmaceutical |
Controlled release preparation
|
SE0203065D0
(sv)
|
2002-10-16 |
2002-10-16 |
Diabact Ab |
Gastric acid secretion inhibiting composition
|
AU2003273000A1
(en)
*
|
2002-10-16 |
2004-05-04 |
Takeda Pharmaceutical Company Limited |
Stable solid preparations
|
CA2501324A1
(en)
*
|
2002-10-30 |
2004-05-21 |
Pharmacia Corporation |
Oral extended release tablets and methods of making and using the same
|
WO2004058228A1
(en)
*
|
2002-12-24 |
2004-07-15 |
Lupin Limited |
Enteric coated fluoxetine composition
|
US20040146558A1
(en)
*
|
2003-01-28 |
2004-07-29 |
Kyowa Pharmaceutical Co., Ltd. |
Oral enteric-coated preparation
|
EP1603537A4
(en)
*
|
2003-02-20 |
2009-11-04 |
Santarus Inc |
IMMEDIATE RELEASE OF OMEPRAZOLE ANTACIDAL COMPLEX WITH NEW FORMULATION FOR RAPID AND PROLONGED ELIMINATION OF GASTRIC ACID
|
WO2004080439A1
(ja)
*
|
2003-03-12 |
2004-09-23 |
Takeda Pharmaceutical Company Limited |
高濃度に活性成分を球形核に付着させた医薬組成物
|
CA2520321A1
(en)
*
|
2003-04-04 |
2004-10-14 |
Pharmacia Corporation |
Oral extended release compressed tablets of multiparticulates
|
BR0300882A
(pt)
*
|
2003-04-09 |
2005-05-10 |
Cmax Otimizacao De Resultados |
Composições farmacêuticas, método e uso de formulação para tratamento e prevenção de infecções associadas com helicobacter pylori em mamìferos e no ser humano
|
PE20050150A1
(es)
|
2003-05-08 |
2005-03-22 |
Altana Pharma Ag |
Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo
|
CL2004000983A1
(es)
|
2003-05-08 |
2005-03-04 |
Altana Pharma Ag |
Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y
|
US8986736B2
(en)
*
|
2003-06-24 |
2015-03-24 |
Baxter International Inc. |
Method for delivering particulate drugs to tissues
|
CA2529984C
(en)
|
2003-06-26 |
2012-09-25 |
Isa Odidi |
Oral multi-functional pharmaceutical capsule preparations of proton pump inhibitors
|
RU2375048C2
(ru)
*
|
2003-07-17 |
2009-12-10 |
Д-Р Редди'С Лабораторис Инк. |
Фармацевтическая композиция с набухающим покрытием
|
US8993599B2
(en)
|
2003-07-18 |
2015-03-31 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
US8313776B2
(en)
|
2003-07-21 |
2012-11-20 |
Shionogi Inc. |
Antibiotic product, use and formulation thereof
|
AU2004258953B2
(en)
|
2003-07-21 |
2011-02-10 |
Shionogi, Inc. |
Antibiotic product, use and formulation thereof
|
EP1648418A4
(en)
|
2003-07-21 |
2011-11-16 |
Middlebrook Pharmaceuticals Inc |
ANTIBIOTIC PRODUCT, ITS USE AND FORMULATION
|
EP1653925A1
(en)
|
2003-08-11 |
2006-05-10 |
Advancis Pharmaceutical Corporation |
Robust pellet
|
AU2004264356B2
(en)
|
2003-08-12 |
2011-01-27 |
Shionogi, Inc. |
Antibiotic product, use and formulation thereof
|
JP5686494B2
(ja)
*
|
2003-08-29 |
2015-03-18 |
シオノギ インコーポレイテッド |
抗生物質製剤、その使用法及び作成方法
|
JP2007504261A
(ja)
*
|
2003-09-03 |
2007-03-01 |
エイジーアイ・セラピューティクス・リサーチ・リミテッド |
プロトンポンプ阻害剤製剤、並びに当該製剤を製造及び使用する方法関連出願の表示
|
WO2005027877A1
(en)
|
2003-09-15 |
2005-03-31 |
Advancis Pharmaceutical Corporation |
Antibiotic product, use and formulation thereof
|
TWI372066B
(en)
*
|
2003-10-01 |
2012-09-11 |
Wyeth Corp |
Pantoprazole multiparticulate formulations
|
US8168228B2
(en)
*
|
2003-10-17 |
2012-05-01 |
Sandoz Ag |
Antibiotic clarithromycin micropellet compositions
|
DE10353186A1
(de)
*
|
2003-11-13 |
2005-06-16 |
Röhm GmbH & Co. KG |
Mehrschichtige Arzneiform, enthaltend eine in Bezug auf die Wirkstoffabgabe modulatorisch wirkende Substanz
|
WO2005051362A2
(en)
*
|
2003-11-28 |
2005-06-09 |
Ranbaxy Laboratories Limited |
Oral benzimidazole compositions comprising an active core, an optional separating layer and an enteric coating
|
US20050181052A1
(en)
*
|
2004-02-17 |
2005-08-18 |
Patel Satishkumar A. |
Lansoprazole microtablets
|
JP2007536349A
(ja)
*
|
2004-05-07 |
2007-12-13 |
ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング |
新規の医薬剤形及び製造方法
|
US8815916B2
(en)
|
2004-05-25 |
2014-08-26 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
US8906940B2
(en)
|
2004-05-25 |
2014-12-09 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
JP5563735B2
(ja)
|
2004-06-16 |
2014-07-30 |
タケダ ファーマシューティカルズ ユー.エス.エー. インコーポレイティド |
Ppi多回剤形
|
JP2008505124A
(ja)
|
2004-07-02 |
2008-02-21 |
アドバンシス ファーマスーティカル コーポレイション |
パルス送達用錠剤
|
DE102004035936A1
(de)
*
|
2004-07-23 |
2006-03-16 |
Röhm GmbH & Co. KG |
Mehrschichtige Arzneiform
|
US10624858B2
(en)
*
|
2004-08-23 |
2020-04-21 |
Intellipharmaceutics Corp |
Controlled release composition using transition coating, and method of preparing same
|
WO2006026829A1
(en)
*
|
2004-09-09 |
2006-03-16 |
Metelli Pty Ltd |
Stable paste composition of enteric coated acid labile active agent and use thereof
|
AR051654A1
(es)
*
|
2004-11-04 |
2007-01-31 |
Astrazeneca Ab |
Nuevas formulaciones de pellets de liberacion modificada para inhibidores de la bomba de protones
|
AR052225A1
(es)
*
|
2004-11-04 |
2007-03-07 |
Astrazeneca Ab |
Formulaciones de tabletas de liberacion modificada par inhibidores de la bomba de protones
|
WO2006067599A2
(en)
|
2004-12-23 |
2006-06-29 |
Ranbaxy Laboratories Limited |
Stable oral benzimidazole compositions and process of preparation thereof
|
US20080279951A1
(en)
*
|
2005-02-02 |
2008-11-13 |
Rajesh Gandhi |
Stable Oral Benzimidazole Compositions Prepared by Non-Aqueous Layering Process
|
CA2600282A1
(en)
*
|
2005-03-29 |
2006-10-05 |
Roehm Gmbh |
Multiparticulate pharmaceutical form comprising pellets with a substance having a modular effect in relation to active ingredient release
|
CN101111231A
(zh)
*
|
2005-03-29 |
2008-01-23 |
罗姆有限公司 |
包含具有影响调节物质递送的基质的小丸的多颗粒药用形式
|
AR054358A1
(es)
*
|
2005-05-13 |
2007-06-20 |
Combino Pharm Sl |
Formulaciones que contienen pantoprazol libre de acido y sus sales
|
US20070087056A1
(en)
*
|
2005-08-09 |
2007-04-19 |
Claudia Guthmann |
Pharmaceutical form with sustained pH-independent active ingredient release for active ingredients having strong pH-dependent solubility
|
KR100591142B1
(ko)
*
|
2005-11-04 |
2006-06-20 |
지엘팜텍 주식회사 |
파록세틴을 활성물질로 함유하는 장용성 서방형 정제
|
WO2007063552A1
(en)
*
|
2005-12-02 |
2007-06-07 |
Lupin Limited |
Stable taste masked formulations of cephalosporins
|
US8778924B2
(en)
|
2006-12-04 |
2014-07-15 |
Shionogi Inc. |
Modified release amoxicillin products
|
US8357394B2
(en)
|
2005-12-08 |
2013-01-22 |
Shionogi Inc. |
Compositions and methods for improved efficacy of penicillin-type antibiotics
|
US10064828B1
(en)
|
2005-12-23 |
2018-09-04 |
Intellipharmaceutics Corp. |
Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
|
EP1803450A1
(en)
*
|
2006-01-03 |
2007-07-04 |
Ferrer Internacional, S.A. |
Pharmaceutical compositions for the eradication of helicobacter pylori
|
WO2007080601A1
(en)
*
|
2006-01-16 |
2007-07-19 |
Jubilant Organosys Limited |
Stable pharmaceutical formulation of an acid labile compound and process for preparing the same
|
WO2007092717A1
(en)
*
|
2006-02-07 |
2007-08-16 |
Fmc Corporation |
Latex or pseudolatex compositions coatings and coating processes
|
DE102006006532B4
(de)
*
|
2006-02-10 |
2007-11-08 |
Biogenerics Pharma Gmbh |
Pharmazeutische Zubereitung
|
US8299052B2
(en)
|
2006-05-05 |
2012-10-30 |
Shionogi Inc. |
Pharmaceutical compositions and methods for improved bacterial eradication
|
US10960077B2
(en)
|
2006-05-12 |
2021-03-30 |
Intellipharmaceutics Corp. |
Abuse and alcohol resistant drug composition
|
WO2007138606A2
(en)
*
|
2006-06-01 |
2007-12-06 |
Dexcel Pharma Technologies Ltd. |
Multiple unit pharmaceutical formulation
|
WO2008015530A2
(en)
*
|
2006-08-03 |
2008-02-07 |
Aurobindo Pharma Limited |
Stable solid oral formulation of pantoprazole
|
ES2385498T3
(es)
*
|
2006-08-18 |
2012-07-25 |
Evonik Röhm Gmbh |
Composición farmacéutica con liberación controlada de la sustancia activa, para sustancias activas con una buena solubilidad en agua
|
CN102014638A
(zh)
|
2007-10-12 |
2011-04-13 |
武田制药北美公司 |
与食物摄入无关的治疗胃肠病症的方法
|
CA2704826A1
(en)
*
|
2007-11-27 |
2009-06-04 |
Ohara Pharmaceutical Co., Ltd. |
Method for producing granulated preparation
|
US8911787B2
(en)
|
2008-02-26 |
2014-12-16 |
Ranbaxy Laboratories Limited |
Stable oral benzimidazole compositions and process of preparation thereof
|
MX2011003595A
(es)
*
|
2008-10-03 |
2011-07-28 |
Falk Pharma Gmbh |
Composiciones y metodos para el tratamiento de enfermedades intestinales con mesalamina granulada.
|
DE102008056312A1
(de)
|
2008-11-07 |
2010-05-12 |
Biogenerics Pharma Gmbh |
Verwendung von Mikrotabletten als Lebens-und Futtermittelzusatz
|
US8945622B2
(en)
|
2009-03-09 |
2015-02-03 |
Council Of Scientific And Industrial Research |
Sustained release composition of therapeutic agent
|
US8663671B2
(en)
|
2009-11-05 |
2014-03-04 |
Philip Morris Usa Inc. |
Methods and compositions for producing hydrogel capsules coated for low permeability and physical integrity
|
WO2011080502A2
(en)
|
2009-12-29 |
2011-07-07 |
Orexo Ab |
New pharmaceutical dosage form for the treatment of gastric acid-related disorders
|
WO2011080500A2
(en)
|
2009-12-29 |
2011-07-07 |
Orexo Ab |
New pharmaceutical dosage form for the treatment of gastric acid-related disorders
|
US20150283083A1
(en)
*
|
2012-11-19 |
2015-10-08 |
Azanta A/S |
Dispersible Tablet
|
JP5934835B2
(ja)
*
|
2013-03-08 |
2016-06-15 |
富士フイルム株式会社 |
腸溶性細粒及び医薬組成物
|
US20140271845A1
(en)
*
|
2013-03-15 |
2014-09-18 |
Cerovene, Inc. |
Coated substrate compositions
|
JP6443891B2
(ja)
*
|
2014-01-31 |
2018-12-26 |
塩野義製薬株式会社 |
徐放性製剤
|
EP3288556A4
(en)
|
2015-04-29 |
2018-09-19 |
Dexcel Pharma Technologies Ltd. |
Orally disintegrating compositions
|
US10076494B2
(en)
|
2016-06-16 |
2018-09-18 |
Dexcel Pharma Technologies Ltd. |
Stable orally disintegrating pharmaceutical compositions
|
UY39094A
(es)
*
|
2020-02-27 |
2021-07-30 |
Hk Inno N Corp |
Composición farmacéutica que comprende compuesto derivado de bencimidazol
|